Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACCS: Aspirin versus Cilostazol in incidental cerebral small vessel disease
PACTR202301861240705Recruiting
- Sponsor
- Hany Aref
- Start
- Feb 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Trial of aspirin and cilostazol in Cerebral Small Vessel Disease (CSVD) (2 arms), sponsored by Hany Aref. Started Feb 2023; status: recruiting.
02
Drugs
aspirincilostazol
03
Conditions
Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on PACTR202301861240705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202301861240705.